4//SEC Filing
Bodenrader Mark 4
Accession 0000950170-23-026500
CIK 0001805387other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 8:07 PM ET
Size
9.2 KB
Accession
0000950170-23-026500
Insider Transaction Report
Form 4
Bodenrader Mark
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2023-06-01+4,733→ 7,417 total - Exercise/Conversion
Restricted Stock Units
2023-06-01−4,733→ 14,199 total→ Common Stock (4,733 underlying) - Sale
Common Stock
2023-06-02$32.95/sh−1,895$62,440→ 5,522 total
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's common stock upon vesting and settlement.
- [F2]Includes 2,684 shares previously acquired under the Issuer's Employee Stock Purchase Plan.
- [F3]The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. Such sales were automatic and intended to qualify under Rule 10b5-1.
- [F4]On June 1, 2022, the Reporting Person was granted 18,932 RSUs under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan. 25% of the RSUs vest on each of the first, second, third and fourth anniversary of June 1, 2022, subject to the Reporting Person's continued service relationship with the Issuer through each such date.
Documents
Issuer
Cerevel Therapeutics Holdings, Inc.
CIK 0001805387
Entity typeother
Related Parties
1- filerCIK 0001830371
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 8:07 PM ET
- Size
- 9.2 KB